Cargando…

The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA

Obesity has become a serious public health problem that has stimulated primordial and primary prevention efforts, and a triad of management options (lifestyle, pharmacotherapy, and surgical interventions). A growing body of evidence supports the need for a multi-pronged, clinic-based approach that l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baum, Charles, Andino, Katherine, Wittbrodt, Eric, Stewart, Shelley, Szymanski, Keith, Turpin, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486408/ https://www.ncbi.nlm.nih.gov/pubmed/25686799 http://dx.doi.org/10.1007/s40273-015-0264-0

Ejemplares similares

Malaria and Economic Evaluation Methods: Challenges and Opportunities
por: Drake, Tom L., et al.
Publicado: (2017)

Pain in Intellectually Disabled Children: Towards Evidence-Based Pharmacotherapy?
por: Valkenburg, Abraham J., et al.
Publicado: (2015)

Pharmacovigilance Considerations for Biosimilars in the USA
por: Grampp, Gustavo, et al.
Publicado: (2015)

Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities
por: Bauchau, Vincent, et al.
Publicado: (2023)

Challenges in the Pharmacologic Management of Obesity and Secondary Dyslipidemia in Children and Adolescents
por: Kennedy, Mary Jayne, et al.
Publicado: (2013)

Towards a more efficient healthcare system: Opportunities and challenges caused by hospital closures amid the COVID-19 pandemic
por: Saghafian, Soroush, et al.
Publicado: (2022)

Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond
por: Gieber, Lisa, et al.
Publicado: (2023)

Interchangeability for Biologics is a Legal Distinction in the USA, Not a Clinical One
por: Park, Joseph P., et al.
Publicado: (2022)

UK Biobank: opportunities for cardiovascular research
por: Littlejohns, Thomas J, et al.
Publicado: (2019)

A Window of Opportunity for Newborn Screening
por: Bailey Jr, Donald B.
Publicado: (2022)

Insulins as Drugs or Biologics in the USA: What Difference Does it Make and Why Does it Matter?
por: George, Kelly, et al.
Publicado: (2019)

Medicines Regulation in Africa: Current State and Opportunities
por: Ndomondo-Sigonda, Margareth, et al.
Publicado: (2017)

Human Resources for Mental Health Care in India - Challenges and Opportunities
por: Murthy, Srinivasa R.
Publicado: (2004)

Power of mentorship for civilian and military acute care surgeons: identifying and leveraging opportunities for longitudinal professional development
por: Knowlton, Lisa Marie, et al.
Publicado: (2023)

Using Economics to Impact Local Obesity Policy: Introducing the UK Centre for Economics of Obesity (CEO)
por: Frew, Emma, et al.
Publicado: (2022)

Revision of Ireland’s Cost-Effectiveness Threshold: New State-Industry Drug Pricing Deal Should Adequately Reflect Opportunity Costs
por: O’Mahony, James F.
Publicado: (2021)

The Challenge of Applying and Undertaking Research in Female Sport
por: Emmonds, Stacey, et al.
Publicado: (2019)

Sea otter health: Challenging a pet hypothesis
por: Lafferty, Kevin D.
Publicado: (2015)

Comparability Considerations and Challenges for Expedited Development Programs for Biological Products
por: Schrieber, Sarah J., et al.
Publicado: (2020)

Financing Drug Innovation in the US: Current Framework and Emerging Challenges
por: Cutler, David, et al.
Publicado: (2020)

The Challenge of Maintaining Metabolic Health During a Global Pandemic
por: King, Andy J., et al.
Publicado: (2020)

Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government
por: van der Pol, Karel H., et al.
Publicado: (2023)

The Origins of the Obesity Epidemic in the USA–Lessons for Today
por: Temple, Norman J.
Publicado: (2022)

Challenging Perceptions About Oncology Product Pricing in Breast and Colorectal Cancer
por: Barron, Anthony, et al.
Publicado: (2016)

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
por: Jit, Mark, et al.
Publicado: (2016)

Challenges in the Evaluation of Emerging Highly Specialised Technologies: Is There a Role for Living HTA?
por: Merlin, Tracy, et al.
Publicado: (2023)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
por: Vogler, Sabine, et al.
Publicado: (2015)

Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence
por: Facente, Shelley N., et al.
Publicado: (2021)

Requirements to Establishing Confidence in Physiologically Based Pharmacokinetic (PBPK) Models and Overcoming Some of the Challenges to Meeting Them
por: Peters, Sheila Annie, et al.
Publicado: (2019)

Current Challenges in Labelling for Generic Medicinal Products: Company Core Data Sheet (CCDS) Development and Maintenance
por: Mueller, Marion, et al.
Publicado: (2020)

Can mRNA Vaccines Turn the Tables During the COVID-19 Pandemic? Current Status and Challenges
por: Sagili Anthony, Deva Priya, et al.
Publicado: (2021)

Genomics in 2011: challenges and opportunities
por: Adams, David J, et al.
Publicado: (2011)

The societal opportunities and challenges of genome editing
por: Carroll, Dana, et al.
Publicado: (2015)

Combination therapies for cancer: challenges and opportunities
por: Zhou, Zhijun, et al.
Publicado: (2023)

Topical pharmacotherapy for allergic rhinitis: Nedocromil
por: Mabry, Richard L.
Publicado: (1993)

Wayfinding: How Ecological Perspectives of Navigating Dynamic Environments Can Enrich Our Understanding of the Learner and the Learning Process in Sport
por: Woods, Carl T., et al.
Publicado: (2020)

From a Technology That Replaces Human Perception–Action to One That Expands It: Some Critiques of Current Technology Use in Sport
por: Woods, Carl T., et al.
Publicado: (2021)

Enskilment: an Ecological-Anthropological Worldview of Skill, Learning and Education in Sport
por: Woods, Carl T., et al.
Publicado: (2021)

Specialist Coaching Integrated into a Department of Methodology in Team Sports Organisations
por: Otte, Fabian W., et al.
Publicado: (2020)

Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?
por: Vass, Caroline M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dgvjc2rrk1h2c6f1oblrlvb1us